about
Guidelines for the use and interpretation of assays for monitoring autophagySubfatin is a novel adipokine and unlike Meteorin in adipose and brain expressionMetrnl: a secreted protein with new emerging functionsPerivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotideArterial remodeling in chronic sinoaortic-denervated rats.Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.Blood pressure variability and organ damage.ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia.Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathwayInvolvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction.Chronic nicotine treatment enhances vascular smooth muscle relaxation in rats.Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferaseDiscovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT.The role of perivascular adipose tissue in vascular smooth muscle cell growth.Loss of AMP-activated protein kinase-α2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle.Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship.Reduction of blood pressure variability: a new strategy for the treatment of hypertension.The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats.Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides.Visfatin and cardio-cerebro-vascular disease.A double-edged sword with therapeutic potential: an updated role of autophagy in ischemic cerebral injury.4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes.NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair.NAMPT as a Therapeutic Target against Stroke.Crystal structure-based comparison of two NAMPT inhibitors.Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNFα action in obesity.Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling.Circulating and local visfatin/Nampt/PBEF levels in spontaneously hypertensive rats, stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats.Telemetric ambulatory arterial stiffness index, a predictor of cardio-cerebro-vascular mortality, is associated with aortic stiffness-determining factors.Effects of six antihypertensive drugs on blood pressure and hypothalamic GABA content in spontaneously hypertensive rats.Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture.Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats.Effects of long-term treatment with candesartan on organ damages in sinoaortic denervated rats.Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats.Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats.
P50
Q21996341-C4A8431D-9388-45F1-8AB6-AF813441E3D4Q24317550-46CDC309-6EE7-4C7F-B0D0-2D38BB66D7F0Q26750482-C0620645-ACE3-4D81-806B-18377D1E1A07Q28575740-D7F8E55D-9F84-4542-9749-70AA87AE885EQ31815833-1772976B-8CE6-4EFF-A216-3BFA7326CF6BQ33677954-68274404-8277-43DF-BF42-BA87801593F6Q33787689-2124F036-57B6-4AC4-BCA8-479ADBE6AA9BQ34366018-B7B5AE2B-053E-4D49-8DB1-6F6267C7C6C2Q34388776-B20EBC26-1373-49CD-8E71-EB3CBABE18ECQ34516226-24A729BB-25CC-4AF2-B317-D6CF8FDF26BBQ35016956-1B1EC33D-7810-4D67-8DEB-E208DE81848AQ35289534-67FF9F40-9997-487A-8E6D-2B4E618C28CEQ35652041-1E47D773-7BCD-4E4A-BFBB-55D31072C0D7Q35727985-46D06D11-AA16-4ADA-9AD9-69A9A9D52F54Q35859753-BC32E9B6-CEB0-48B4-A626-356993F5B616Q35902863-016BF4ED-AEE4-4544-9FFD-E326BC4C2C71Q35970879-30503766-0842-45A9-AB4D-2853E39098D0Q36180178-CEFBA327-F98A-4E0E-A49E-A43F12CE5D7AQ37294696-5938C6BB-5A23-4473-B8CC-032FDA91C778Q37399380-155B152E-4D3E-4542-9703-E5BA8B6ECC82Q37832378-A020092B-18F9-44C9-9460-D1383AA0494DQ38045416-4F1C7029-640B-4F4F-B4CC-B05C5225A4ADQ38349253-12ED6B64-2898-4861-99F3-416C071016D5Q38612163-1E65ECCA-6876-45AF-B3BA-CBE44E73911FQ38625625-B8CE64B8-45A8-4FC9-953D-7A6D8685CBEDQ38635017-0820C56B-9B17-4B9B-8F63-E41B817C973CQ38790406-5812BE84-EC89-4D7C-8F39-1648412C070CQ38804682-62AA648F-C3C8-468E-B791-E3F7428326AFQ40851556-9864FCC3-D6A1-40D0-B392-AAA42ED7B19CQ41909845-018CEF80-9D96-4EB6-828A-64C8E0975E06Q42818830-A2EF09C8-08F8-43B4-9D7D-DF686CA77F42Q42823688-D1C21F2D-125A-4FE4-8569-4AD89A58B289Q42958361-DD98B2E9-20B9-45D5-BA0F-7526EA8AAC28Q43702481-8A6F6B9E-8B49-4ABD-B34E-6E301FDB874AQ43742810-CBD9DF88-440B-4B07-A038-EBE2DD592AEDQ44287622-A52E10FB-1B53-48FF-81C3-2F1C5DCF97DFQ44291370-8C685A98-377B-4BE0-A9AB-FAC1D8CD7918Q44291403-306ABAF5-A8F4-40E5-A11D-AADB3D1C7044Q44326275-2D97C5C2-4341-471E-BE09-B5F6B92D82FCQ44506116-EA9A1609-D17F-40CA-98C9-1B34A8393DEE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chao-Yu Miao
@ast
Chao-Yu Miao
@en
Chao-Yu Miao
@es
Chao-Yu Miao
@nl
type
label
Chao-Yu Miao
@ast
Chao-Yu Miao
@en
Chao-Yu Miao
@es
Chao-Yu Miao
@nl
prefLabel
Chao-Yu Miao
@ast
Chao-Yu Miao
@en
Chao-Yu Miao
@es
Chao-Yu Miao
@nl
P106
P31
P496
0000-0002-8176-3434